The electrochemical behavior of pyridoxine was studied in 0.1 mol × L−1 NaX (X = F, Cl, Br) support electrolyte on a gold electrode using cyclic voltammetry and UV–Vis spectrophotometry. The influence of gold nanoparticles (AuNPs) on the electrochemical behavior of pyridoxine was studied. The experimental results obtained by both cyclic voltammetry and UV–Vis spectrophotometry indicate strong interactions in the B6 and NaBr/NaCl_AuNP systems, while in the NaF_B6_AuNP ternary system the results indicate a mechanism of direct electrochemical degradation of vitamin B6. The experimental results obtained for the electrochemical degradation of pyridoxine, in the presence of chloride and bromide ions, indicate strong interactions in the NaCl_B6_AuNP and NaBr_B6_AuNP systems associated with the spectrophotometric identification of the electrogenerated intermediates, while in the presence of fluoride ions no such products are identified. The development of the mechanism of electrochemical degradation of the pyridoxine molecule predicts both the formation of the corresponding electrogenerated intermediates and the steps of electro-incineration in a direct mechanism.
In order to anticipate the effect induced by a natural product on the chemical activity of medicines simultaneously administered, spontaneous interactions of certain cancer treatment drugs such as, epirubicin (EPR), gemcitabine (GCT), and paclitaxel (PTX) with limonene (LIM)—a natural compound extracted from orange peel and known as an anticancer agent—were investigated. To estimate the stability of the drugs over time, a current density of 50 mA cm−2 was applied as an external stimulus between two platinum electrodes immersed in hydrochloric acid solution containing ethyl alcohol/water in the volume ratio of 2/3, in the absence and presence of orange essential oil (limonene concentration of 95%). The concentration variation of chemotherapeutic agents over time was evaluated by UV-Vis spectrophotometry. Kinetic studies have shown a delay in the decomposition reaction of epirubicin and gemcitabine and a paclitaxel activity stimulation. Thus, in the presence of limonene, the epirubicin half-life increased from 46.2 min to 63 min, and from 6.2 min to 8.6 min in gemcitabine case, while for paclitaxel a decrease of half-life from 35.9 min to 25.8 min was determined. Therefore, certain drug-limonene interactions took place, leading to the emergence of molecular micro-assemblies impacting decomposition reaction of chemotherapeutics. To predict drug–limonene interactions, the Autodock 4.2.6 system was employed. Thus, two hydrophobic interactions and five π-alkyl interactions were established between EPR-LIM, the GCT-LIM connection involves four π-alkyl interactions, and the PTX-LIM bridges take place through three hydrophobic interactions and the one π-alkyl. Finally, the decomposition reaction mechanism of drugs was proposed.
This study provides evidence on the stability of vitamin K1 (VK) in the form of phytomenadione, in the absence and presence of a therapeutic preparation, as the gold nanoparticles (AuNPs), under the effect of sodium halide ions. The degradation susceptibility of the two compounds was assessed individually and in mixtures by cyclic voltammetry and electrolysis at a constant current density assisted by UV-Vis spectrophotometry. Their interactions with the halide ions differently impact on the electrochemical processes as follows: (i) the fluoride ions weakly affects the VK/AuNP stability and compatibility; (ii) the presence of chloride ions leads to VK/AuNP stability, for a short time and restrictive compatibility; (iii) bromide ions induce instability and incompatibility of the VK/AuNP system; (iv) spontaneous interactions between VK/AuNPs and iodide ions take place, consequently defining as an unstable and incompatible system.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.